---
figid: PMC9437486__fphar-13-924826-g006
figtitle: Astragaloside IV attenuates ferroptosis after subarachnoid hemorrhage via
  Nrf2/HO-1 signaling pathway
organisms:
- NA
pmcid: PMC9437486
filename: fphar-13-924826-g006.jpg
figlink: /pmc/articles/PMC9437486/figure/F6/
number: F6
caption: Schematic representation of the neuroprotective effect of AS-IV treatment
  after SAH. AS-IV inhibits ferroptosis via enhancing Nrf2/HO-1 signaling pathway,
  thereby ameliorating EBI 24 h after SAH in rats.
papertitle: Astragaloside IV attenuates ferroptosis after subarachnoid hemorrhage
  via Nrf2/HO-1 signaling pathway.
reftext: Zhuanghua Liu, et al. Front Pharmacol. 2022;13:924826.
year: '2022'
doi: 10.3389/fphar.2022.924826
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: astragaloside IV | subarachnoid hemorrhage | ferroptosis | early brain injury
  | nuclear factor erythroid-2 related factor 2
automl_pathway: 0.9435827
figid_alias: PMC9437486__F6
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC9437486__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9437486__fphar-13-924826-g006.html
  '@type': Dataset
  description: Schematic representation of the neuroprotective effect of AS-IV treatment
    after SAH. AS-IV inhibits ferroptosis via enhancing Nrf2/HO-1 signaling pathway,
    thereby ameliorating EBI 24 h after SAH in rats.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KEAP1
  - GABPA
  - NFE2L2
  - HMOX1
  - SLC7A11
  - GPX4
  - TBL1X
  - ACSM3
  - Keap1
  - cnc
  - Ho
  - ebi
  - sah
---
